Form D — Kairos Pharma, LTD.
0001493152-25-003984 · filed 2025-01-28
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $8,750,000
- Total sold
- $3,497,500
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Kairos Pharma, LTD.
- CIK
- 1962011
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2355 WESTWOOD BLVD., #139
LOS ANGELES, CA 90064 - Phone
- (310) 948-2356
Related persons
-
John S. Yu · Executive OfficerLos Angeles, CA
-
Doug Samuelson · Executive OfficerLos Angeles, CA
-
Ramachandran Murali · Executive OfficerLos Angeles, CA
-
Neil Bhowmick · Executive OfficerLos Angeles, CA
-
Hyun W. Bae · DirectorLos Angeles, CA
-
Hansoo Michael Keyoung · DirectorLos Angeles, CA
-
Rahul Singhvi · DirectorLos Angeles, CA
View original on SEC EDGAR.